Seasonal Influenza
See our full Influenza virus product range including all the WHO recommended vaccine strains antigens for 2025 Southern and Northern Hemisphere as well as H5N1 Bird flu strains.
Matched Pair Antibodies
Enhance your antigen assay development with The Native Antigen Company’s newest market-leading tool!
.
New range of HIV-1 and HIV-2 Antigens
We are pleased to announce comprehensive range of trimeric, native-like HIV-1 gp140 antigens! Learn more by clicking the button below.
Powered by BiozAbout The Native Antigen Company
The Native Antigen Company develops and manufactures premium quality antigens and antibodies as well as offering a range of services to the diagnostic and biopharmaceutical industries.
Our proprietary VirtuE™ expression system has been developed for the purpose of producing native-like proteins, which are widely adopted by leading in vitro diagnostic, vaccine and academic groups in cutting-edge R&D, where correct folding and glycosylation are vital. Our contract services range from antibody generation, to scale production of recombinant and native antigens, and bespoke assay development and QC.
Building on our recognised expertise in infectious diseases, we are expanding our portfolio to include a range of disease-state markers and other critical reagents for human health.